Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. As a global leader in the animal health industry, we are working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals.
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim.
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.
The Boehringer Ingelheim Cares Foundation Patient Assistance Program (Boehringer Cares) is provided by the Boehringer Ingelheim Cares Foundation, an independent nonprofit organization that seeks to help eligible patients receive medicines for free. The Program provides Boehringer Ingelheim medicines free of charge to U.S. patients who meet our program eligibility requirements. Our goal is to ...
Boehringer Ingelheim zählt weltweit zu den 20 führenden Pharmaunternehmen mit über 130 Jahren Erfahrung.
Topline Phase 3 results of survodutide—licensed to Boehringer Ingelheim from Zealand Pharma—are more comparable to Novo Nordisk’s Wegovy than to Eli Lilly’s Zepbound, William Blair analysts said on ...
Business Wire: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
Yahoo: Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study